在自身免疫性风湿性疾病中常见的间歇性肺炎的免疫抑制疗法:一篇评论
Domenico Sambataro1, Giulia Morina2, Alessandro Libra2
1Outpatient Clinic Associated with the Regional Health System, Artroreuma s.r.l., 95030 Mascalucia (CT), Italy.
Medicina (Kaunas, Lithuania)
|April 26, 2025
概括
在自身免疫性疾病中常见的间歇性肺炎 (UIP) 显示出对免疫抑制的相互矛盾的反应. 虽然一些疾病,如类风湿性关节炎显示出希望,其他人,如系统性硬化可能会恶化,需要进一步的研究.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 常见间歇性肺炎 (UIP) 是一种严重的间歇性肺病 (ILD) 模式,通常与异常性肺纤维化 (IPF) 相关.
- UIP也经常发生在自身免疫性风湿性疾病 (ARD) 中,与IPF共享风险因素和遗传背景.
- 免疫抑制疗法不推用于IPF,但其在ARDs-ILD中的作用是有争议的.
研究的目的:
- 审查自身免疫性UIP的临床表现.
- 总结目前关于对UIP的免疫抑制治疗的知识,以ARDs为次要.
主要方法:
- 在PubMed搜索有关ARDs-ILD治疗的英语临床试验和研究.
- 专注于ARD中UIP的特定治疗方法 (UIP-ARDs).
主要成果:
- 临床试验往往缺乏按ILD模式和安慰剂组分层.
- 与系统性硬化症相关的UIP显示出与免疫抑制恶化的趋势.
- 在具有自身免疫特征的间歇性肺炎和与类风湿关节炎相关的UIP中观察到免疫抑制治疗有前途的结果.
结论:
- 对UIP-ARDs的免疫抑制治疗的证据有限且相互矛盾.
- 迫切需要具体的临床试验,类似于IPF的临床试验.
- 不同的ARD可能对免疫抑制有独特的反应,组织学样本可以提供有价值的见解.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Autoimmune Disorders
2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
710
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
710
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
793
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
793
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
660
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
660
Pulmonary Tuberculosis I
1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K


